CIE Automotive India Q2 CY26 Sales Rise 11% to ₹2,540 Cr; EBITDA Up 17%

AUTO
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
CIE Automotive India Q2 CY26 Sales Rise 11% to ₹2,540 Cr; EBITDA Up 17%

CIE Automotive India reported an 11% rise in consolidated sales to ₹2,540 crore for Q2 CY26. EBITDA grew 17% to ₹420 crore. The company is focusing on investment discipline and portfolio restructuring.

Detailed Coverage

CIE Automotive India Reports Strong Q2 CY26 Performance

Consolidated Sales: ₹2,540 crore
Consolidated EBITDA: ₹420 crore

Reader Takeaway: Healthy growth driven by European recovery, but India faces margin pressures.

What just happened

CIE Automotive India announced its Q2 CY26 financial results, showing a consolidated sales increase of 11% year-on-year to ₹2,540 crore. Consolidated EBITDA rose by 17% to ₹420 crore. The company maintained a net cash position of ₹-1,420 crore for H1 CY26.

Why this matters

The results indicate the company's ability to grow topline and profitability, even amidst challenging market conditions. The improved European performance and strategic capacity expansions signal a focus on long-term value creation. However, margin moderation in India due to cost inflation warrants close observation.

The backstory

CIE Automotive India has been undergoing a strategic shift, emphasizing investment discipline and portfolio restructuring. This has led to some underperformance in growth metrics recently, partly due to exiting loss-making aluminum product lines and navigating export headwinds.

What changes now

The company is pushing forward with capacity expansions in its Iron Foundry, Gears, and Stamping divisions. Management expects to implement measures to address cost inflation in India over the next two quarters. Investors are looking for improved transparency and granularity in disclosures.

Risks to watch

Potential risks include the anticipated gradual slowing of growth in India due to macroeconomic factors, ongoing inflationary pressures on energy and consumables in India, and the company's historical underperformance compared to some peers, despite its focus on ROI.

Peer comparison

While the filing doesn't directly compare with peers, management's response to investor queries highlighted a strategic difference: focusing on Return on Investment (ROI) and sustainable growth over aggressive market share pursuit, which might explain growth lags compared to some competitors.

Context metrics (time-bound)

  • Consolidated Sales (Q2 CY26): ₹2,540 crore (+11% YoY)
  • Consolidated EBITDA (Q2 CY26): ₹420 crore (+17% YoY)
  • Net Financial Debt (H1 CY26): ₹-1,420 crore (Net Cash)
  • India Sales (Q2 CY26): ₹1,650 crore (+13% YoY)
  • Europe Sales (Q2 CY26): ₹890 crore (+7% YoY)
  • India EBITDA Margin (Q2 CY26): 16.7% (vs. 17.5% YoY)
  • Europe EBITDA Margin (Q2 CY26): 15.9% (vs. 12.5% YoY)
  • Return on Net Assets (RONA) (H1 CY26): 19.4%

What to track next

Investors will be keen to observe the implementation of countervailing measures against cost inflation in India, the actualization of new export project revenues, and any improvements in disclosure granularity as promised by management.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.